Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of the American College of Cardiology

• Publication date

  2005-09-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JACC.2005.05.071PMID 16168296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era.

  2004cited by this paper
• Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis

  2004cited by this paper
• Lipoprotein Lipase Gene Polymorphisms in Croatian Patients with Coronary Artery Disease

  2003cited by this paper
• Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: Evidence for an antiinflammatory role for lipoprotein lipase

  2003cited by this paper
• Estimation of Multilocus Haplotype Effects Using Weighted Penalised Log‐Likelihood: Analysis of Five Sequence Variations at the Cholesteryl Ester Transfer Protein Gene Locus

  2003cited by this paper
• Fighting restenosis after coronary angioplasty: contemporary and future treatment options.

  2002cited by this paper
• Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.

  2002cited by this paper
• Inflammation and Restenosis in the Stent Era

  2002cited by this paper
• The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease

  2001cited by this paper
• Genetic variation at the lipoprotein lipase locus and plasma lipoprotein and insulin levels in the Québec Family Study.

  2001cited by this paper
• Potentially protective effects of the Ser447-Ter mutation of the lipoprotein lipase gene against the development of coronary artery disease in Japanese subjects via a beneficial lipid profile.

  2001cited by this paper
• Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids.

  2001cited by this paper
• Adenoviral Expression of a Urokinase Receptor–Targeted Protease Inhibitor Inhibits Neointima Formation in Murine and Human Blood Vessels

  2001cited by this paper
• Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa heart study.

  2001cited by this paper
• Marker Selection by Akaike Information Criterion and Bayesian Information Criterion

  2001cited by this paper
• Chemokine expression in coronary circulation after coronary angioplasty as a prognostic factor for restenosis.

  2001cited by this paper
• Lipoprotein lipase activity is associated with severity of angina pectoris. REGRESS Study Group.

  2000cited by this paper
• Lipoprotein Lipase Activity Is Associated With Severity of Angina Pectoris

  2000cited by this paper
• Lipoprotein lipase (C/G)447 polymorphism and blood pressure in the Stanislas Cohort

  2000cited by this paper
• Accelerated atherosclerosis by placement of a perivascular cuff and a cholesterol-rich diet in ApoE*3Leiden transgenic mice.

  2000cited by this paper
• Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease A Meta-Analysis

  1999cited by this paper
• Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study.

  1999cited by this paper
• Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis.

  1999cited by this paper
• Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins.

  1999cited by this paper
• A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study

  1999cited by this paper
• A multilocus genotyping assay for candidate markers of cardiovascular disease risk.

  1999cited by this paper
• Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice.

  1998cited by this paper
• Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS).

  1998cited by this paper
• Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions.

  1998cited by this paper
• Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty.

  1997cited by this paper
• Segments in the C-terminal Folding Domain of Lipoprotein Lipase Important for Binding to the Low Density Lipoprotein Receptor-related Protein and to Heparan Sulfate Proteoglycans*

  1997cited by this paper
• Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.

  1997cited by this paper
• Lipoprotein lipase can function as a monocyte adhesion protein.

  1997cited by this paper
• Lipoprotein lipase enhances human monocyte adhesion to aortic endothelial cells.

  1997cited by this paper
• Ser447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic males.

  1997cited by this paper
• Genetic Variant Showing a Positive Interaction With β-Blocking Agents With a Beneficial Influence on Lipoprotein Lipase Activity, HDL Cholesterol, and Triglyceride Levels in Coronary Artery Disease Patients: The Ser447-Stop Substitution in the Lipoprotein Lipase Gene

  1997cited by this paper
• Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function.

  1996cited by this paper
• Molecular pathobiology of the human lipoprotein lipase gene.

  1996cited by this paper
• The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study.

  1996cited by this paper
• Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Témoin sur l'Infarctus du Myocarde.

  1995cited by this paper
• Nitric oxide--biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis.

  1995cited by this paper
• Lipoprotein lipase synergizes with interferon gamma to induce macrophage nitric oxide synthetase mRNA expression and nitric oxide production.

  1995cited by this paper
• DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population.

  1994cited by this paper
• The L-arginine-nitric oxide pathway.

  1993cited by this paper
• Can restenosis after coronary angioplasty be predicted from clinical variables?

  1993cited by this paper
• Mutational analysis of human lipoprotein lipase by carboxy-terminal truncation.

  1993cited by this paper
• Lipoprotein lipase: cellular origin and functional distribution.

  1990cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Влияние генетических факторов, участвующих в регуляции метаболизма липидов, на результаты чрескожных коронарных вмешательств

  2018cites this paper
• Influence of lipoproteinlipaze gene polymorphism on outcomes in patients undergoing percutaneous coronary interventions

  2018cites this paper
• Systematic Testing of Literature Reported Genetic Variation Associated with Coronary Restenosis: Results of the GENDER Study

  2012cites this paper
• Quantitative Trait Locus Analysis of Neointimal Formation in an Intercross Between C57BL/6 and C3H/HeJ Apolipoprotein E–Deficient Mice

  2009cites this paper
• Enhanced atherothrombotic formation after oxidative injury by FeCl3 to the common carotid artery in severe combined hyperlipidemic mice.

  2009cites this paper
• Quantitative trait locus analysis of neointimal formation in an intercross between C 57 BL / 6 and C 3 H / HeJ apolipoprotein E-deficient mice

  2009cites this paper
• A genome wide association analysis in the GENDER study

  2009cites this paper
• Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease.

  2008cites this paper
• Restenosis begets restenosis: implications for stent selection

  2008cites this paper
• Epigenetic histone acetylation modifiers in vascular remodelling – new targets for therapy in cardiovascular disease

  2008cites this paper
• Vascular lipases, inflammation and atherosclerosis.

  2006cites this paper
• Lipoprotein lipase S447X : from benefical gene variant to gene therapy

  2006cites this paper